Baher Elgohari

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

87

H-Index

1

About

Dr. Baher Elgohari is a radiation oncologist whose research focuses on optimizing treatment outcomes for head and neck cancers, particularly oropharyngeal cancer. His major contributions lie in comparing the functional and oncologic outcomes of surgical versus nonsurgical therapies, with a special emphasis on swallowing preservation. His highly cited 2019 study in *JAMA Otolaryngology–Head & Neck Surgery* (87 citations) provided critical evidence on dysphagia outcomes after primary transoral robotic surgery (TORS) with neck dissection versus nonsurgical therapy for low- to intermediate-risk oropharyngeal cancer. This work helped clarify the trade-offs between treatment modalities, guiding personalized treatment decisions that balance cancer control with quality of life. Dr. Elgohari’s research has been instrumental in advancing the field of head and neck oncology, particularly in understanding how modern surgical techniques compare to radiation-based approaches. His work continues to influence clinical practice and shape the conversation around functional preservation in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
87
Total Citations
87
Avg Citations/Paper
🏆 Most Cited Paper
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
87 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago